Novo Nordisk A/S (NVO) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novo Nordisk A/s Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.588 -- 00:00:05.796 Good day and thank you for standing by. Welcome to the Q1 2025 Novo Nordisk 00:00:05.796 -- 00:00:11.004 AS Earnings Conference call. At this time, all participants are in a listen-only mode. 00:00:11.004 -- 00:00:14.649 After the speaker's presentation, there'll be a question and answer session. 00:00:14.649 -- 00:00:19.697 To ask a question during the session, you will need to press star 1 and 1 on your telephone. 00:00:19.697 -- 00:00:23.482 You will then hear an automated message advising your hand is raised. 00:00:23.482 -- 00:00:26.847 To withdraw your question, please press star 1 and 1 again. 00:00:26.847 -- 00:00:30.406 Please be advised that today's conference is being recorded. 00:00:30.406 -- 00:00:34.390 I would now like to have the comments of your first speaker today, Jakob Rode, Head of 00:00:34.390 -- 00:00:38.292 Investor Relations. Please go ahead, sir. 00:00:39.055 -- 00:00:43.240 Thank you. And welcome to this Novo Nordisk earnings call for the first three months 00:00:43.240 -- 00:00:44.941 of 2025. 00:00:44.941 -- 00:00:48.565 My name is Jakob Rode, and I'm the Head of Investor Relations at Novo Nordisk. 00:00:48.565 -- 00:00:53.490 And with me today I have CEO of Novo Nordisk, Lars Brugger Jørgensen, Executive Vice 00:00:53.490 -- 00:00:58.155 President, U.S. Operations, Dave Moore, Executive Vice President, International Operations, 00:00:58.155 -- 00:01:02.506 Mike Duster, Executive Vice President and Head of Development, Martin Holtz-Lange, and 00:01:02.506 -- 00:01:05.931 finally, Chief Financial Officer, Carsten von Klosen. 00:01:05.931 -- 00:01:08.895 All speakers will be available for the Q&A session. 00:01:08.895 -- 00:01:13.120 Today's announcement and the slides for this call are available on our w...